Poland· PL-100377440
Clarithromycin Genoptim
A clarithromycin product containing clarithromycinum, registered in Poland by Synoptis Pharma Sp. z o.o.. The same ATC class is registered in 19 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Clarithromycin is registered in 19 of 19 countries.
Countries holding a registration under ATC J01FA09 (clarithromycin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 11 of them publish a price we can compare per daily dose
Clarithromycin · ATC J01FA09
19 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of clarithromycin costs, country by country.
Normalised to the WHO defined daily dose (0.5 g), the median price runs from $0.65 in Italy to $2.90 in Switzerland — a ×4.5 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Clarithromycin · price per daily dose (0.5 g)
USD · FX 28 Sept 2026
- CH Switzerland$2.90
- FR France$0.94
- IT Italy$0.65
The record
At a glance
URPL (Poland)- Active substance
- Clarithromycinum
- Manufacturer
- Synoptis Pharma Sp. z o.o.
- Country
- Poland (PL)
- ATC code
- J01FA09
- ATC class
- Clarithromycin
- Defined daily dose
- 0.5 g, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 3
- gtin05909991414320
- gtin05909991414337
- gtin05909991414344
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
1085 interactions on record for clarithromycin.
Graded by severity as the source publishes them — 274 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Clarithromycin · interactions on record
1085 records
- 274 severe
- 434 moderate
- 50 minor
- 256 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- NaloxegolA06AH03severe
71 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Clarithromycin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCLARITHROMYCIN TEVATeva Pharmaceuticals CR, s.r.o., Praha
- FinlandBinoclarSandoz GmbH
- SpainCLARITROMICINA ALTER 250 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Alter S.A.
- FranceCLARITHROMYCINE ACCORD 250 mg, comprimé pelliculéACCORD HEALTHCARE FRANCE
- United StatesClarithromycinSportpharm LLC
- SwitzerlandClarithromycin Sandoz
- BelgiumBiclar 250 mgViatris Healthcare
- IrelandClarithromycin 250 mg film-coated tabletsSun Pharmaceutical Industries Europe B.V.
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Clarithromycin 1a Pharma, Clarithromycin Accord
- Belgium · Biclar, Biclar Forte
- Bulgaria · Lekoklar, Oрадро
- Cyprus · Clarem, Claripen
- Czechia · Clarithromycin Hameln, Clarithromycin Teva
- Germany · Clarilind, Clarithromycin 1 A Pharma
- Denmark · Clarithromycin ”hameln”, Clarithromycin Accord
- Estonia · Fromilid, Fromilid Uno
- Spain · Claritromicina Accord, Claritromicina Almus
- Finland · Clarithromycin Hexal, Clarithromycin Krka
- France · Clarithromycin Teva, Clarithromycine Abbott
- United Kingdom (Northern Ireland) · Clarithromycin, Clarithromycin Accord Healthcare
- Greece · Clarimex, Claripen
- Croatia · Fromilid, Fromilid Uno
- Hungary · Clarithromycin 1 A Pharma, Clarithromycin Azevedos
- Ireland · Clarithromycin Accord Healthcare Ireland, Clarithromycin Amdipharm Limited
- Iceland · Clarithromycin Krka
- Italy · Clamodin, Claritrol
- Lithuania · Clarithromycin Ingen Pharma, Clarithromycin Teva
- Luxembourg · Biclar, Biclar Forte
- Latvia · Clarithromycin Ingen Pharma, Clarithromycin Teva
- Malta · Clarem, Clarithromycin Accord Healthcare
- Netherlands · Clarithromycin Aurobindo, Claritromycine Accord
- Norway · Clarithromycin Accord, Clarithromycin Teva
- Portugal · Claritromicina, Claritromicina Altan
- Romania · Fromilid, Fromilid Uno
- Sweden · Clarithromycin Krka, Klacid
- Slovenia · Fromilid, Fromilid Uno
- Slovakia · Clarithromycin Hameln, Fromilid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ebe0bb06-39c3-4867-910b-17858ad032aa GET /v1/drugs/ebe0bb06-39c3-4867-910b-17858ad032aa?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "250 mg",
"packaging": "05909991414320 ¦ Rp ¦ 134103\n10 tabl.\n05909991414337 ¦ Rp ¦ 134104\n14 tabl.\n05909991414344 ¦ Rp ¦ 134105\n28 tabl.",
"substance": "Clarithromycinum 250 mg",
"common_name": "Clarithromycinum",
"pl_product_id": "100377440",
"pozwolenie_nr": "25594",
"auth_procedure": "NAR",
"authorisation_validity": "2024-01-16"
}See everything about clarithromycin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.